The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs
- 30 June 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (6) , 1578-1592
- https://doi.org/10.1016/s0149-2918(03)80157-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Subtherapeutic INR Values Associated with a Switch to Generic WarfarinAnnals of Pharmacotherapy, 2001
- Low-dose oral contraceptives: health consequences of discontinuationContraception, 2000
- Is Generic Prescribing Acceptable in Epilepsy?Drug Safety, 2000
- Drug substitution in transplantation: A National Kidney Foundation white paperAmerican Journal of Kidney Diseases, 1999
- Pharmacological Effects of Antiarrhythmic DrugsArchives of internal medicine (1960), 1998
- Impact of Generic Substitution of Anticonvulsants on the Treatment of EpilepsyCNS Drugs, 1997
- Generic prescribing for epilepsy. Is it safe?Seizure, 1996
- Generic substitutions for antiepileptic drugsNeurology, 1990
- Recurrence of ventricular tachycardia after conversion from proprietary to generic procainamideThe American Journal of Cardiology, 1989
- Medical and economic consequences of a blinded oral anticoagulant brand change at a municipal hospitalArchives of internal medicine (1960), 1988